A team of PSU researchers aims to develop evaluation tools for AI's response to students' mathematical reasoning, focusing on feedback quality and relevance. The two-year project will use real math tasks and data visualization reasoning to test AI models' ability to recognize and respond to student thinking.
Insilico Medicine will attend London Investor Conferences and Dubai Future Week, highlighting its AI-driven drug discovery and longevity efforts. The company's CEO, Dr. Alex Zhavoronkov, and President, Dr. Alex Aliper, will deliver keynote speeches and participate in panel discussions on cutting-edge AI biotech trends.
Researchers introduced a framework for evaluating AI tools in psychological assessment, finding that AI models can score well on accuracy measures while missing key signs of mental health concerns. The study recommends a more rigorous testing process to ensure valid psychological assessments.
Adam Dziedzic's ERC starting grant project aims to develop tools to identify where data comes from and how it's used in AI models, with a focus on detecting AI-generated content and ensuring trustworthy AI models. The project combines weak signals to build strong evidence and introduces digital marks that AI models do not forget.
Researchers at Lehigh University are developing a model that uses causal auditing and symbolic reasoning to improve the transparency and accountability of LLM-based recommender systems. This could help users better understand why a particular recommendation was made and what information influenced it.
A new AI tool, PREVIA, analyzes patients' narratives about injuries to predict who will later develop PTSD, correctly identifying over 95% of at-risk patients. This tool could help clinicians catch the condition early, as it is designed to be a quick and efficient screening method.
Insilico Medicine CEO Dr. Alex Zhavoronkov and President Dr. Alex Aliper will speak at the FT Healthcare Summit and Revive ME 2026 about longevity medicine and generative biology. They will discuss the company's translational path, evidence standards, and regulatory frameworks for longevity medicine.
A team led by Marinka Zitnik is developing an agentic AI system to assist cancer researchers in analyzing data, generating hypotheses, and suggesting new experiments. The system will work alongside human researchers to increase the efficiency and effectiveness of cancer research.
Insilico Medicine releases Longevity Grok, a 24/7 AI system that unifies personal health records, tracks biological analysis, and provides personalized lifestyle interventions. The system also drives communal AI-powered geroscience research and features a zero-trust architecture for data privacy.
Researchers at the University of Sydney have identified a fundamental mathematical reason why AI systems can learn different behaviors even when trained under almost identical conditions. The study found that extremely small differences in a model's starting conditions can lead to different outcomes, revealing a fractal structure in the
Generative AI models consume significantly more energy when processing and generating text in non-English languages, with some languages requiring up to 15 times more energy than English. This energy disparity can exacerbate existing global inequalities and make AI less accessible to millions of people worldwide.
Researchers found that chatbots attribute stable personality profiles to themselves over time, presenting themselves as more conscientious and emotionally stable. Humans, however, are more reliable at identifying personality traits in texts, and chatbots tend to rate human-written texts higher than AI-generated texts.
A recent study found that 7% of adults experienced AI-generated image-based abuse, with 87% reporting impacts on their health, wellbeing, and relationships. The study highlights the need for greater responsibility on technology companies to prevent AI-generated image-based abuse before it occurs.
NTU Singapore and Google are expanding their partnership to accelerate AI adoption across education, research, and workforce readiness. The collaboration will support faculty training, professional certification, and region-specific AI initiatives, while advancing frontier scientific research and AI safety.
Insilico Medicine will deliver keynote speeches on competitive landscape and AI commoditization at the China Healthcare Summit. The company showcases its robust pipeline momentum and platform translational capability at the 9th China International Import Expo (CIIE).
A team of researchers, led by University of Florida professor Sumit Jha, has developed a system called ATLAS to detect and correct AI agents that drift from their assigned tasks. The system works inside large language models, steering them back on track without retraining or significant computing demands.
The new 'Four As' framework for AI governance aims to balance competition and innovation with safeguards against harmful capabilities. It identifies four key areas: Action, Access, Authority, and Allocation, and requires proportionate safeguards, human control, and regular reassessment.
A study by Radboud University found that users rate chatbots with fluent language as intelligent and useful, even if they provide incorrect information. The research highlights the danger of blind trust in artificial intelligence and suggests that making uncertainty visible is key to protecting users.
Researchers from URochester and NVIDIA have developed a new model, PixelDiT, that provides pixel-level control over AI image generation, improving image quality and controllability. The model allows users to zero in on specific regions of an image, fixing details such as glasses or car colors.
A study found that nearly half of severely distressed generative AI users seek emotional support from platforms like ChatGPT and Gemini. This raises concerns about the risks of relying on AI during periods of emotional vulnerability. The study highlights the need for better understanding of AI's benefits and risks in mental health supp...
A new study by Edith Cowan University found that travellers consider GenAI for travel planning based on reliability, accountability, trustworthiness, fairness, and transparency. Excessive transparency can reduce willingness to use AI, highlighting the importance of balancing information with trust.
A novel framework uses AI and social media to identify promising brand collaborations, providing practical guidance for brand managers. The framework has been tested and validated, showing a nearly 90% chance of correctly identifying favorable brand pairs.
Insilico Medicine announced promising Phase 1 data for ISM6331, a pan-TEAD inhibitor designed using generative AI, showing a 40.0% objective response rate at 130 mg once daily in heavily pretreated mesothelioma. The drug also demonstrated disease control in more than two-thirds of evaluable participants.
A Rutgers study found that 1 in 3 young adults (18-29 years) use AI for substance-use information, primarily seeking risks and consequences. The study highlights the need for research on how young adults interpret and understand AI outputs on substance use, with implications for public health.
Insilico Medicine executives will share insights on leveraging generative AI in drug discovery and healthcare delivery at Dubai AI Festival 2026 and the 2026 Global Healthcare Innovation Summit in Hong Kong. In Seoul, Dr. Jue Wang will deliver a keynote on maximizing AI's value in AI drug discovery at BioPlus-Interphex Korea 2026.
inClinico Agent automates and optimizes clinical trial intelligence, predicting trial outcomes with high accuracy. The platform achieves an overall AUROC of 0.805 and an accuracy of 0.734, with Phase 3 trial accuracy reaching 0.780.
Researchers at HIPS used AI to design new building blocks for active ingredient production, resulting in functional proteins with improved pharmaceutical properties. The AI-designed building blocks increased yield up to three times compared to natural variants, making it easier to obtain new compounds for research and development.
Insilico Medicine has achieved the early drug discovery milestone in its multi-year AI-driven drug discovery collaboration with Servier, triggering an undisclosed milestone payment. The milestone triggers an undisclosed payment from Servier to Insilico, following the successful fulfillment of predefined program criteria.
Large language models, used in chat-based AI platforms, have been found to possess internal mechanisms that create consistency in their risk assessments. Despite being unable to rely on previous data, models' assessments remained remarkably consistent after hundreds of repetitions. The study's findings suggest that AI systems are more ...
Insilico Medicine will exhibit its AI-driven drug discovery and anti-aging science at the Abu Dhabi Future Health Summit and the Regenerative Medicine Congress 2026. The company's CEO will participate in panel discussions and deliver a keynote speech on the future of drug discovery and generative AI.
Researchers at UC3M and University de Zaragoza are developing AI-driven epidemiological models that can replicate human behavior during epidemics, incorporating socioeconomic factors and social determinants. The project aims to create more accurate models that can inform public health decisions and reduce existing inequalities.
Researchers at the University of Tokyo developed a new AI model, MatterGen-e, which designs electronic structure and crystal structure together for new materials. The model produces substantially more valid and novel structures than a previous model, and provides density of states for newly generated materials.
Researchers used AI to analyze nearly 150,000 Reddit posts about unapproved GLP-1 weight loss drug retatrutide, identifying potential side effects that differ from clinical trial results. The study found increased appetite to be the most frequently reported symptom, which contrasts with gastrointestinal complaints identified in Phase 2...
Researchers Dr. Hutan Ashrafian and Dr. Ahmad Guni discuss the expanding capabilities of medical AI, including predictive and preventive applications, and the need for technical and health-system advances to improve health outcomes. They will explore the safeguards needed for responsible and equitable adoption of increasingly capable A...
Pharma.AI's MMAI Gym enables scientists to adapt AI models to specific tasks, achieving performance matching or exceeding the state of the art across 70 chemistry and biology benchmark tasks. The company also introduced Generative Biologics, Chemistry42, and PandaOmics, providing tools for designing and predicting properties of molecul...
Artificial intelligence can match human doctors in certain tasks, but human doctors are essential for making complex decisions about patient care. AI may identify a patient's medical condition, but human doctors must consider individual circumstances and make choices that work in the patient's best interest.
Researchers developed LEMon-AID, an AI framework that analyzes subtle emotional patterns in casual speech to identify youths at high risk of psychosis. The approach achieved 67% predictive accuracy and detected 93% of at-risk individuals.
Insilico Medicine has nominated ISM9546, an orally bioavailable VAV1 degrader, as a potential treatment for autoimmune diseases. The compound has shown sub-nanomolar VAV1 degradation potency and robust efficacy in preclinical studies.
This theme issue explores innovative research on engagement as a primary outcome, investigating psychosocial factors, novel measurement strategies, and real-world innovations. JMIR Publications seeks research that contributes to the field's evolving understanding of engagement to build more sustainable, user-centered health technologies.
Researchers are developing new approaches to model interconnected biological processes, identify opportunities for intervention, and translate insights into measurable improvements in human health. Longevity therapeutics face an actionable regulatory framework to ensure clinical validation and market access.
A new paper explores how chatbot health guidance leaves no trace for clinicians, regulators, and users, highlighting the need for transparency safeguards. The authors propose methods to increase transparency and responsibility for AI companies, including access to user conversations, disclosure systems, and third-party monitoring.
Researchers developed a mathematical formula to predict when AI models will switch from safe to dangerous responses. The formula, based on
A new book series from CRC Press and the Association for the Advancement of Artificial Intelligence (AAAI) aims to address crucial questions about AI ethics and its implications in education and beyond. The series, Advances in AI Ethics, will provide actionable guidance on using AI safely and responsibly.
A recent study at the University of Eastern Finland found that using AI to seek feedback and identify missing perspectives leads to significantly better student performance. In contrast, instrumental use of AI can lower grades, highlighting the importance of teaching students how to use AI effectively.
A new Horizon Europe project, FIMI-RESIST, aims to evaluate the effectiveness of existing European tools against disinformation. The project, led by Johannes Gutenberg University Mainz, will assess 20 EU-funded tools using common criteria and shared benchmarks.
A new study found that large language models prefer existing conditions over change, which could hinder climate progress. Researchers assessed 11 LLMs and found that they recommended decisions already made by users more than 70% of the time.
Researchers found gaps in social media platforms' communication about online risks to children, including lack of transparency about safety features and data collection. AI chatbots also failed to recognize the real need behind caregiver questions, highlighting the potential gap between technological support and human needs.
The new resources, created using Google's Gemini Notebook, offer interactive tools and video/audio overviews to deepen engagement with childhood development research. Dr. Jacqueline Harding's books provide accessible guidance on early childhood development, play, and human connection.
The American Academy of Pediatrics has published guidance on the safe use of generative artificial intelligence (AI) in pediatric clinical care. The policy statement emphasizes the importance of prioritizing data relevant to children's care, addressing bias, and ensuring strong data privacy and security safeguards. This framework aims ...
This section will publish peer-reviewed research on the clinical value of AI in cardiovascular medicine, including evidence of effectiveness and impact on access and equity. Submissions are invited on various topics, including clinical diagnosis, multimodal data integration, and implementation in real-world cardiovascular care.
A new framework trains AI models to screen AI-generated content using performance data from past marketing campaigns. The models provide content recommendations and ratings, streamlining the decision-making process for marketers. Human capital plays a vital role in the successful use of these new technologies.
Insilico Medicine will present its latest advances in LLM-driven drug discovery, autonomous robotics labs, and interdisciplinary scientific breakthroughs at AI Everything Abu Dhabi and BioJapan 2026. The company's leaders will also share insights into AI biology of aging, anti-aging interventions, and longevity drug discovery at the Ab...
A proof-of-concept study tested three techniques for alerting users to hallucinated statements from embodied AI agents in VR systems. The findings suggest that embodied cues improve immersion, text cues offer clear interpretability, and icon cues strike a middle ground.
Researchers developed the Motion Style Slider framework for continuous control of motion style intensity in generated human animation. The framework achieves consistent style control and smooth transitions using only two motion samples, allowing animators to refine character performances according to their creative vision.
Insilico Medicine nominates ISM1354, a novel small molecule GIPR antagonist, with robust weight-loss efficacy and improved pharmacokinetic and safety profiles. ISM1354 demonstrates a favorable safety profile, with minimal effects on cell viability and a lower potential hepatotoxicity risk.
A study of 100,000 young adults found that those using generative AI for health questions are more likely to screen positive for anxiety and depression, with odds increasing by 52% for anxiety and 46% for depression. The study suggests an association between AI use and mental health but does not establish causation.
Researchers found that AI chatbots give users a uniform range of information, similar to a conventional web search, but with a narrower scope. The study's authors warn of 'knowledge collapse' as language models become increasingly trained on AI-generated text, potentially reducing diversity and nuance.
Researchers developed an AI approach to predict glioblastoma recurrence, allowing for targeted treatments before the cancer becomes visible on MRI. The tool uses microscopic images of fresh, unprocessed tissue and scored based on tumor infiltration, with an accuracy of predicting recurrence within 5-10 millimeters of the sampled tissue.
The Pharma.AI 2026 Q3 Fall Update showcases the rise of agentic AI in pharmaceutical intelligence, automating discovery workflows with autonomous agents. Insilico Medicine's platforms, including Generative Biologics, PandaOmics, and Chemistry42, demonstrate the power of agentic AI in accelerating drug discovery and development.
Research reveals that AI tools can either strengthen or weaken critical thinking skills in school children, with 67 out of 139 studies showing positive effects. The use of AI in education is still largely unexplored, with gaps in knowledge about its impact on children and youths.